NCT03245580View on ClinicalTrials.gov

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

NACompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

March 8, 2018

Primary Completion Date

September 15, 2020

Study Completion Date

September 15, 2020

Conditions
Liver Diseases
Interventions
DIAGNOSTIC_TEST

Core Liver Biopsy

Diagnostic EUS examination followed by liver biopsy to obtain core sample in benign liver disease.

Trial Locations (7)

17822

Geisinger Medical Center, Danville

36608

University South Alabama, Mobile

46202

Indiana University, Indianapolis

46845

Parkview Regional Medical Center, Fort Wayne

70121

Oschner Health System, New Orleans

77030

Baylor Medical Center, Houston

95128

Santa CLara Valley Medical Center, San Jose

Sponsors

Lead Sponsor

Parkview Health
All Listed Sponsors
lead

Parkview Health

OTHER

NCT03245580 - Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease) | Biotech Hunter | Biotech Hunter